RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 29 2024
0mins
Source: Businesswire
Investigation of Merger: Former Louisiana Attorney General Charles C. Foti, Jr. and Kahn Swick & Foti, LLC are investigating the proposed merger between Reneo Pharmaceuticals and OnKure, focusing on its fairness to Reneo shareholders.
Shareholder Rights: KSF is offering assistance to shareholders regarding their legal rights related to the merger, providing contact information for inquiries without obligation.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
